Eva Renee Barnett
2023
In 2023, Eva Renee Barnett earned a total compensation of $2.1M as Chief Financial Officer at Immunovant, a 53% decrease compared to previous year.
Compensation breakdown
| Bonus | $414,430 |
|---|---|
| Option Awards | $636,078 |
| Salary | $435,000 |
| Stock Awards | $562,952 |
| Other | $21,635 |
| Total | $2,070,095 |
Barnett received $636.1K in option awards, accounting for 31% of the total pay in 2023.
Barnett also received $414.4K in bonus, $435K in salary, $563K in stock awards and $21.6K in other compensation.
Rankings
In 2023, Eva Renee Barnett's compensation ranked 498th out of 2,910 executives tracked by ExecPay. In other words, Barnett earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 498 out of 2,910 | 83rd |
Division Manufacturing | 288 out of 1,602 | 82nd |
Major group Chemicals And Allied Products | 199 out of 901 | 78th |
Industry group Drugs | 196 out of 864 | 77th |
Industry Biological Products, Except Diagnostic Substances | 68 out of 211 | 68th |
Source: SEC filing on June 26, 2023.
Barnett's colleagues
We found two more compensation records of executives who worked with Eva Renee Barnett at Immunovant in 2023.